v3.25.4
Stockholders' Equity
 3 Months Ended
Jan. 31, 2026
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
Note 8. Stockholders' Equity
Analysis of Changes in Accumulated Other Comprehensive Loss:
(In millions)Foreign Currency Translation AdjustmentMinimum Pension LiabilityDerivative InstrumentsTotal
Balance at October 31, 2024$(461.7)$(4.9)$44.9 $(421.7)
Gross change in value(66.7)— (2.5)(69.2)
Tax effect— — 0.5 0.5 
Balance at January 31, 2025$(528.4)$(4.9)$42.9 $(490.4)
Balance at October 31, 2025$(426.2)$1.7 $18.0 $(406.5)
Gross change in value76.5 — (5.3)71.2 
Tax effect— — 1.3 1.3 
Balance at January 31, 2026$(349.7)$1.7 $14.0 $(334.0)
Share Repurchases
In September 2025, the authorization under the 2012 Share Repurchase Program was increased to $2.0 billion by the Company's Board of Directors. As of January 31, 2026, $873.9 million remains authorized for repurchase.
During the three months ended January 31, 2026, the Company repurchased 1.1 million shares of its common stock for $92.5 million, at a weighted average price of $82.04 per share. There were no share repurchases during the three months ended January 31, 2025.